Skip to content
CMS listens to BIO and understands proposed policies could have harmed patients, innovation
A new suite of rules governing drug rebates in Medicaid has been finalized, removing months of uncertainty about whether the Centers for Medicare and […]
BIO’s View
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
I am BIO Podcast: Biotechnology is national security technology
American leadership in biotechnology is a vital national security asset in need of protection now, and its importance can be expected to grow in
I am BIO Podcast: Biotechnology is national security technology Read More »
BIO and BBC StoryWorks call for biotech stories
Since 2019, the Biotechnology Innovation Organization (BIO) has worked with BBC StoryWorks Commercial Productions, the BBC’s award-winning branded content division, to bring stories of
BIO and BBC StoryWorks call for biotech stories Read More »
Virginia Gov. Youngkin named BIO’s Governor of the Year
Virginia Gov. Glenn Youngkin on Sept. 17 received the 2024 Governor of the Year Award from the Biotechnology Innovation Organization (BIO) in recognition of
Virginia Gov. Youngkin named BIO’s Governor of the Year Read More »
BIO’s John Torres on his appointment to the ATAC and the future of agricultural trade
John Torres, Senior Director, Federal Government Relations – Agriculture and Environment at the Biotechnology Innovation Organization (BIO), was recently appointed to the U.S. Department
BIO’s John Torres on his appointment to the ATAC and the future of agricultural trade Read More »
BIO’s view: Sanders’ latest attack on innovation misses realities about groundbreaking drugs
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he will hold a hearing
Four key facts ahead of tomorrow’s drug pricing hearing
The Senate Finance Committee will hold a hearing tomorrow on “understanding the benefits of the Inflation Reduction Act.” Expect to hear a lot of rhetoric
Four key facts ahead of tomorrow’s drug pricing hearing Read More »
New survey checks pulse on voters’ concerns for innovation and biomanufacturing
Voters want to bolster American manufacturing across biopharmaceutical and biotechnology sectors, according to a new public opinion survey conducted by Morning Consult for the
New survey checks pulse on voters’ concerns for innovation and biomanufacturing Read More »
GEN State of Biotechnology 2024: John F. Crowley on driving biotech forward
“The world of biotechnology is in the midst of a wave of exciting research and clinical advances—from artificial intelligence-based drug discovery to cell and
GEN State of Biotechnology 2024: John F. Crowley on driving biotech forward Read More »
The economics of the Inflation Reduction Act’s impact on innovation
The announcement of “maximum fair prices” for the first 10 medicines targeted under the Inflation Reduction Act (IRA) has renewed questions and concerns about
The economics of the Inflation Reduction Act’s impact on innovation Read More »